pH sensitive properties of Tc(V)-DMS: Analytical and in vitro cellular studies

被引:14
作者
Horiuchi, K [1 ]
Saji, H
Yokoyama, A
机构
[1] Kyoto Univ, Fac Pharmaceut Sci, Dept Patho Funct Bioanal, Sakyo Ku, Kyoto 6068501, Japan
[2] Fukui Med Univ, Biomed Imaging Res Ctr, Fukui 91011, Japan
关键词
pentavalent technetium-99m dimercaptosuccinic acid; Tc(V)-DMS; pH effect; pH-sensitive agent; ligand concentration;
D O I
10.1016/S0969-8051(98)00044-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Numerous clinical studies with the pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] seem to indicate its new role in nuclear oncology. Thus, we questioned what properties of the Tc(V)-DMS molecule associate with its tumoral tissue accumulation. Because studies have reported tumor tissue to be more acidic than normal tissue, acidification might be related to the Tc(V)-DMS localization in tumor tissue, Thus, in the present study, a working hypothesis drew to test the acidification as a plausible factor, and various analytical methods and an in vitro cellular system using Ehrlich ascites tumor cells (EATC) implemented. Analytical methodologies demonstrated the decrease of the overall negative charge of the Tc(V) DMS molecule, promoted by the acidification of the analytical medium and the sample dilution. In the in vitro cellular experiment, acidification alone showed no effect on the radioactivity accumulation in EATC; nevertheless, if accompanied by a pre-dilution of the Tc(V)-DMS sample added into the cell incubation media, cellular radioactivity accumulation was observed. Thus, acidification as a mediator for the Tc(V) DMS accumulation in tumoral cells, concurrently with dilution as the promoter of the process, constituted the,foundation for discerning the working hypothesis. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:689 / 695
页数:7
相关论文
共 34 条
[21]  
OHTA H, 1988, NUCL MED COMMUN, V9, P105
[22]  
OHTA H, 1984, J NUCL MED, V25, P323
[23]   IMAGING OF SOFT-TISSUE TUMORS WITH TC(V)-99M DIMERCAPTOSUCCINIC ACID A NEW TUMOR-SEEKING AGENT [J].
OHTA, H ;
ENDO, K ;
FUJITA, T ;
NAKAJIMA, T ;
SAKAHARA, H ;
TORIZUKA, K ;
SHIMIZU, Y ;
HATA, N ;
MASUDA, H ;
HORIUCHI, K ;
YOKOYAMA, A ;
IKEKUBO, K ;
INOUE, N ;
TAMURA, K ;
KOTOURA, Y ;
ISHII, M ;
YOSHIZUMI, M .
CLINICAL NUCLEAR MEDICINE, 1984, 9 (10) :568-573
[24]  
Schneider W., 1984, COMMENTS INORG CHEM, V3, P205, DOI DOI 10.1080/02603598408078138
[25]  
SILLEN LG, 1971, ACS MONOGRAPH 168, V1, P491
[26]   CRYSTAL-STRUCTURE AND ISOMERISM OF A TUMOR TARGETING RADIOPHARMACEUTICAL - [REO(DMSA)2]- (H2DMSA = MESO-2,3-DIMERCAPTOSUCCINIC ACID) [J].
SINGH, J ;
POWELL, AK ;
CLARKE, SEM ;
BLOWER, PJ .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1991, (16) :1115-1117
[27]   CHEMICAL AND H-1-NMR SPECTROSCOPIC INVESTIGATIONS OF STEREOISOMERIC TC(V) DMSA COMPLEXES [J].
SPIES, H ;
SCHELLER, D .
INORGANICA CHIMICA ACTA, 1986, 116 (01) :1-4
[28]  
TANNOCK IF, 1989, CANCER RES, V49, P4373
[29]  
WATKINSON JC, 1989, J NUCL MED, V30, P174
[30]   The mechanism of Ga-67 localization in malignant disease [J].
Weiner, RE .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (06) :745-751